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Abstract
Background: Antibiotics are widely-used medicines for which a more prudent use has been
advocated to minimize development of resistance. There are considerable cross-national
differences that can only partially be explained by epidemiological difference and variations in health
care structure. The aim of this study was to explore whether cross-national differences in use of
antibiotics (prescribed and non-prescribed) are associated with differences between national
cultures as described in Hofstede's model of cultural dimensions (Power Distance, Individualism,
Masculinity, Uncertainty Avoidance and Long-Term Orientation).
Methods: Country-level data of prescribed antibiotic use and self-medication with antibiotics were
correlated to country-specific scores of cultural dimensions obtained from Hofstede. Data on use
of antibiotics were provided by three European studies, based on different methods and/or
countries: Self-medication with Antibiotics and Resistance in Europe (SAR), based on a survey in
2003 on reported use of antibiotics in 19 countries, the European Surveillance on Antimicrobial
Consumption, based on distribution and reimbursement of antibiotics in ambulatory care (1997–
2002), and the 2002 interview-based Eurobarometer study, asking whether respondents had taken
antibiotics in the previous 12 months. These studies provided data on antibiotics use for 27
European countries in total, for which scores of cultural dimensions were also available. The SAR-
study differentiated between prescribed antibiotics and self-medication with antibiotics.
Results: Significant positive correlations were found for Power Distance Index with use of
prescribed antibiotics in the three studies (rho between 0.59 and 0.62) and with self-medication
(rho = 0.54) in the SAR study. Positive significant correlations were found for the Uncertainty
Avoidance Index with the use of antibiotics as reported in two studies (rho between 0.57 and 0.59;
for the SAR study the correlations were insignificant). Masculinity was not significantly correlated,
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Conclusion: Power Distance is a cultural aspect associated with antibiotic use, suggesting that the
culture-specific way people deal with authority is an important factor in explaining cross-national
differences in antibiotic use. There are indications that Uncertainty Avoidance also plays a role but
further research is needed to better understand the complex effect of cultural dimensions.
Background
Antibiotics are important and widely used medicines
[1,2]. There is however a growing concern as the use of
these medicines leads to resistance, avoidable costs and
adverse reactions [1-3]. Hence it has been advocated to
avoid unnecessary use [4].
Many studies have shown the relevance of characteristics
of the doctor [5,6] or the patient [7,8], or the doctor-
patient relationship [8-10] for the use of antibiotics. There
are also considerable cross-national differences in public
attitudes towards antibiotics use [7,11,12] as well as in
actual use of prescribed antibiotics [2,13] and self-medi-
cation with antibiotics [14]. These cross-national differ-
ences in use of antibiotics can only partially be explained
by epidemiological differences and variations in health
care structure. Cultural factors also are known to play an
important role in illness behaviour and consumption of
antibiotics [11,12,15-17]. Most cross-cultural compari-
sons are about factors directly related to illness behaviour
(e.g. labelling and presumed causes of illnesses). Few
studies have explored the broader and general cultural
characteristics of a country that at first sight are not
directly related to illness behaviour [18]. One of the diffi-
culties in many studies is that the concept of culture is
often used as a general concept for all inexplicable cross-
national differences. It is also hard to operationalise the
concept of culture into quantifiable measures that can be
used in comparative studies.
Several models and questionnaires have been developed
to analyse cultural differences [19-21]. One of the most
popular approaches is Hofstede's model of cultural
dimensions [22]. These dimensions are aspects from
which a culture can be compared with other cultures. They
provide a relatively general framework for analysis that
can be easily applied because it reduces the complexities
of culture and its interactions into quantifiable dimen-
sions [20,22,23]. Initially 4 cultural dimensions were
found on which countries can be scored: Power Distance
(PDI), Individualism (IDV), Masculinity (MAS) and
Uncertainty Avoidance (UAI). Later the study has been
replicated in other settings and other countries. Based on
a Chinese Value Survey, a fifth dimension was found:
Long-versus Short-Term Orientation (LTO) [20].
Power Distance refers to the degree of hierarchy in a coun-
try. It has been defined by Hofstede as the extent to which
the less powerful members of organizations and institu-
tions accept and expect that power is distributed une-
qually. A lower score indicates a preference for
deliberation and mutual dependence between subordi-
nates and their chief and authority based on secular/
rational arguments. Individualism refers to the prevalence
of the interests of an individual versus the group. This
dimension is defined as the degree to which individuals
are integrated into groups. A higher score indicates more
emphasis on individualism. Masculinity, as opposed to
femininity, refers to a culture in which the emotional roles
of the two genders are clearly separated. A higher score
indicates for instance that a culture is assertive and com-
petitive. Uncertainty Avoidance deals with a society's tol-
erance for uncertainty and ambiguity. A higher score
indicates that people feel uncomfortable in novel,
unknown or surprising situations. Values associated with
Long Term Orientation are thrift and perseverance; in con-
trast, a low score on this dimension implies values associ-
ated with Short Term Orientation: respect for tradition,
fulfilling social obligations, protecting one's 'face' and
expecting quick results.
While the influence of cultural dimensions on illness
behaviour and use of medicines has been suggested in
previous studies, [24,25] very few studies have actually
linked the scores on cultural dimensions with diseases
and illness behaviour [11,26].
Although antibiotics are used worldwide and their effec-
tiveness is unquestionable, these medicines are the result
of a particular view on illness, the so-called germ para-
digm [27,28]. It incorporates some assumptions that were
typical of a certain worldview in a particular (scientific)
community and time, e.g. a reductionist approach assum-
ing that a disease is caused by one (simple) cause: a germ.
Within such a paradigm, antibiotics are ideal medicines.
Alternatively, other approaches might put more emphasis
on the inner resistance of the person or prefer 'to let
nature run its course' [18]. If these worldviews and cul-
ture-specific assumptions, of which people are usually
unaware and hence are seldom scrutinised, play a role, it
becomes plausible that cultural dimensions also affect
peoples' opinions, attitudes and use of antibiotics.Page 2 of 9
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ago what effect on antibiotic use could be expected of
these cultural dimensions [29,30].
Power Distance has to do with preferences of how persons
with a different status communicate with each other.
Hence, one might expect that this will also play a role in
patient-doctor communication. A preference for delibera-
tion about the use and sense of antibiotics might be
favoured in countries with low Power Distance, as con-
trasted with a 'doctor knows best'-attitude in countries
scoring high for Power Distance.
Another hypothesis was that countries with high Uncer-
tainty Avoidance would use more antibiotics because doc-
tors try to avoid the ambiguity in cases of ailments such as
'a cold' or 'the flu', which are usually – but not always –
trivial, self-limiting viral infections. Prescribing antibiot-
ics is then a coping-strategy, much like a ritual, to reduce
the uncertainty. In such countries patients too might have
problems accepting a doctor saying no exact diagnosis can
be given and therefore one should just 'wait and see'.
With regard to Individualism physicians face the problem
that prescribing antibiotics for the individual patient
increases the risk of resistance for the population as a
whole. The same holds with regard to Long versus Short
term Orientations: antibiotics are expected to give quick
results but the prescribing of antibiotics now raises the
risk of making them ineffective in the future.
Masculinity can be expected to correlate positively with
the use of antibiotics, e.g. because these countries are
strongly result-oriented and value a 'live to work' ethic. In
such countries antibiotics might be favoured because they
are often perceived and used as strong medicines that can
get you back to work more quickly. Conversely, feminine
cultures are more concerned with ecological problems
and might therefore be expected to pay more attention to
problems of antibiotic resistance.
Based on these hypotheses, it has been suggested that
Power Distance and Uncertainty Avoidance were corre-
lated with antibiotic consumption [16,17]. However, cul-
tural aspects linked to the suboptimal use of antibiotics
remained a point of particular interest calling for a better
understanding [16].
The aim of this study is to test the aforesaid hypotheses
and to further explore whether cultural dimensions are
significantly correlated with cross-national differences in
the prescribed use of antibiotics and self-medication with
antibiotics.
Methods
Data on the use of antibiotics were provided by three
European studies, based on different methods and coun-
tries.
In the 'Self-medication with antibiotics and Resistance in
Europe' (SAR) study, data were obtained from a survey in
2003 on the reported use of systemic antimicrobial drugs
in the last year in 19 European countries. A multistage
sampling design was used in each participating country.
Within each country, a region with average prescribed
antibiotic consumption was chosen, based on available
national data on the use of medicines. However, in some
countries these data were not available at the start of the
SAR study, and a region representative of the country's
population in terms of age and sex was chosen (Poland,
Czech Republic, Lithuania, Croatia, Romania). In each
region an urban area (population 75,000 – 350,000) and
a rural area (population 5,000–10,000) were selected.
Persons over 18 years of age were randomly selected from
population registries in the selected regions. The question-
naire was developed specifically for this survey in English,
translated into national languages, and back-translated
for consistency. The SAR study could differentiate
between prescribed antibiotics and self-medication with
antibiotics. The questionnaire is available in English from
the corresponding author. More information is provided
elsewhere [14]. Respondents were classified as self-medi-
cating if they reported that they had taken any antimicro-
bial drugs in the previous 12 months without a
prescription from a physician, dentist, or nurse and as pre-
scribed users if antimicrobial drugs had been prescribed.
For all countries in the SAR-study with a response rate
higher than 20%, prevalence of reported self-medication
and prescribed use of antibiotics in the previous 12
months per 1000 population were estimated [14].
In the European Surveillance on Antimicrobial Consump-
tion, data were based on either distribution or reimburse-
ment of systemic antibiotics in ambulatory care for the
period 1997–2002. Data were collected in 24 countries
that provided internationally comparable data. Addi-
tional information about the characteristics of the data
sources and data providers, obtained from the national
ESAC representatives, was used to check validity of the
data [2].
The Eurobarometer provided data based on face-to-face
interviews of stratified at random samples of inhabitants,
aged 15 years or older, in 15 countries. Samples consisted
of at least 1000 persons per country (except for Luxem-
burg (N = 602) and Northern Ireland (N = 302)) and were
compared to the total population. Respondents were
asked whether or not they had taken antibiotics in the last
12 months [13].Page 3 of 9
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ede [23]. For an initial set of 40 countries, Hofstede
derived these indexes from carefully matched samples of
employees in different national subsidiaries of the same
multinational corporation IBM, between 1967 and 1973
[20]. Later additions used a simplified questionnaire, the
Values Survey Module (VSM) 1994 [31]. It consisted of 14
content questions, scored on a five-point scale. The mean
score for each country has been calculated, giving the
index-value per country. The most recently published lists
contain index values on the first four dimensions for 74
countries and regions [23]. Indexes refer to relative differ-
ences between countries. In the original study they varied
between 0–100, but later, countries were added with
higher scores. These findings have been replicated in a
number of successive studies by different researchers
using a variety of other matched samples of respondents
[32]. For an overview see Hofstede, 2001 [20].
For the SAR study ethic or data committee approval was
required and obtained for 11 countries [14]. For the other
datasets we used data collected and published by other
research teams.
Spearman's correlation coefficient rho was used to calcu-
late correlations between country-aggregated use of anti-
biotics and country-specific scores of cultural dimensions.
A p-value of 0.05 or smaller was considered significant.
Since some cultural dimensions are known to covary with
affluence [20,33], we examined the potential effects by
calculating the partial correlations controlled for Gross
Domestic Product per capita [34] and then compared the
controlled correlation with the original correlation.
Results
Two countries from the SAR study and two from the ESAC
study could not be included because of lack of data on
Hofstede's cultural dimensions (table 1). Hence correla-
tions for 4 of the 5 cultural dimensions could be calcu-
Table 1: Use of antibiotics and index scores on four cultural dimensions.
SAR CULTURAL DIMENSIONS(e)
No. Respondents(a) Prescribed use of 
antibiotics(b)
Self-medication with 
antibiotics(b)
ESAC(c) EURO BARO 
METER(d)
PDI IDV MAS UAI LTO
Sweden 704 (69%) 135 4 31 71 5 29 33
Netherlands 1634 (55%) 152 1 10 24 38 80 14 53 44
Austria 442 (28%) 159 9 12 34 11 55 79 70 31
Denmark 1881 (63%) 172 7 13 22 18 74 16 23 46
Poland 935 (32%) 199 33 21 - 68 60 64 93 32
UK 675 (23%) 221 12 14 40 35 89 66 35 25
Belgium (Fl.) 1734 (54%) 222 9 25 40 61 78 43 97 38
Czech Rep. 1169 (59%) 253 7 17 - 57 58 57 74 13
Lithuania 747 (25%) 275 210 - - 42 60 19 65 -
Luxemburg 675 (50%) 288 9 27 41 40 60 50 70 -
Slovenia 1143 (38%) 293 17 17 - 71 27 19 88 -
Romania 430 (43%) 307 198 - - 90 30 42 90 -
Ireland 793 (26%) 353 14 20 44 28 70 68 35 43
Malta 541 (54%) 422 56 - - 56 59 47 96 -
Croatia 615 (31%) 439 31 22 - 73 33 40 80 -
Italy 213 (21%) 512 62 25 44 50 76 70 75 34
Slovakia 546 (55%) 569 42 22 - 104 52 110 51 38
Bulgaria - - - 17 - 70 30 40 85 -
Estonia - - - 12 - 40 60 30 60 -
Finland - - - 18 36 33 63 26 59 41
France - - - 32 45 68 71 43 86 39
Germany - - - 13 26 35 67 66 65 31
Greece - - - 30 40 60 35 57 112 -
Hungary - - - 15 - 46 80 88 82 50
Norway - - - 15 - 31 69 8 50 44
Portugal - - - 27 44 63 27 31 104 30
Spain - - - 19 45 57 51 42 86 19
(a) response rate between brackets
(b) use of antibiotics in the past 12 months, prevalence rate per 1000 respondents [14]
(c) total outpatient antibiotic use in DDD (defined daily dose) per 1000 inhabitants per day [2]
(d) percentage of persons who said they used antibiotics in the past 12 months [13]
(e) indexes of cultural dimensions [23].Page 4 of 9
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study, 24 from the ESAC-study and 15 from the Euroba-
rometer study [2,13,14]. For Long-term versus short-term
orientation, fewer correlations could be calculated
because indexes on the latter dimension were available for
only 18 of the 27 countries.
Significant positive correlations were found for Power
Distance Index with prescribed use of antibiotics in the
three studies (with correlations varying from rho = 0.59 to
0.62; table 2).
Positive correlations were found for the Uncertainty
Avoidance Index with the use of antibiotics as reported in
the three studies (rho between 0.57 and 0.59). For the SAR
study correlations are not significant, however.
For Individualism, Masculinity and Long-Term versus
short-term Orientation the correlations were not signifi-
cant.
Self-medication was only significantly correlated with
Power Distance (rho = 0.54).
When controlling for the Gross Domestic Product (GDP)
per capita, the correlations changed for Power Distance
and Uncertainty Avoidance and became not significant.
Correlations were also insignificant for Individualism and
Long Term Orientation. For Masculinity the correlations
tend to become stronger but they were significant for only
one dataset (Eurobarometer: r = 0.81).
Discussion
The findings of positive correlations for antibiotic use
with Power distance and, in 2 of the 3 studies with Uncer-
tainty Avoidance, corroborate our hypotheses with regard
to these dimensions. When controlling the correlations
between cultural dimensions and antibiotics for wealth,
only one correlation (for Masculinity and the Eurobarom-
eter results for antibiotic use) is significant.
Our findings may have implications with regard to the
more rational use of antibiotics and might help us to
improve our understanding of why there are such remark-
able differences in antibiotic use. The effect of Power Dis-
tances is complex and might work on several levels. The
preference for consultation and secular/rational argu-
ments, which is typically of countries with low scores on
Power Distance, may have implications for collaboration
between doctors and other health care providers, such as
pharmacists and nurses, as well as for doctor-patient com-
munication. In countries with a high Power Distance,
hierarchic differences are more manifested and doctors
may therefore have a more pronounced (therapeutic)
autonomy, whereas in other countries one can expect doc-
tors to feel more part of a team. In the Netherlands (a
country with a low Power Distance and one of the lowest
use of antibiotics) Pharmacotherapy Counselling Groups,
in which GPs and local community pharmacists regularly
meet to exchange information about drug therapy, have
been the spearhead of a successful policy for more rational
use of antibiotics and other medicines [18,35,36].
Power Distance is also supposed to affect the doctor
patient-relationship, as well as the relations between pro-
fessionals. In countries with a high Power Distance it is
likely that patients look up to their doctor, expecting great
expertise and feeling little need for involvement in the
decision-making. A doctor asking "what do you think
yourself about taking an antibiotic?" would embarrass the
'modal' patient. Likewise, a physician acknowledging that
he is not sure whether it is a viral or bacterial infection will
not inspire much confidence in such a cultural context.
Prescribing antibiotics has strong symbolic connotations
Table 2: Correlations between use of antibiotics and cultural dimensions
PDI p-value IDV p-value MAS p-value UIA p-value LTO p-value
SAR Self-medication (N = 17) 0.54 0.026 -0.41 0.104 0.31 0.228 0.43 0.086 -0.12g 0.722
SAR Prescribed use (N = 17) 0.59 0.012 -0.45 0.072 0.42 0.094 0.32 0.208 -0.02g 0.958
ESAC (N = 24) 0.59 0.003 -0.29 0.166 0.22 0.308 0.59 0.003 -0.13h 0.620
Eurobarometer (N = 15) 0.62 0.014 -0.30 0.280 0.31 0.259 0.57 0.025 -0.39i 0.190
Controlled for GDP/capita
SAR Self-medication (N = 17) 0.23 0.41 0.615 -0.03 0.10 0.948 0.61 0.58 0.150 0.19 0.26 0.683 0;00g 0.998
SAR Prescribed use (N = 17) 0.362 0.831 0.172 0.572 -0.01g 0.977
ESAC (N = 24) 0.72 0.067 0.09 0.851 0.38 0.395 0.55 0.206 -0.07h 0.887
Eurobarometer (N = 15) 0.50 0.249 0.10 0.834 0.81 0.027 0.50 0.252 -0.50i 0.255
g) based on 11 cases
h) based on 18 cases
i) based on 13 casesPage 5 of 9
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Hence antibiotics have a communicative aspect as well as
the pharmaceutical one. The clinician-patient encounter
has been described as 'one of the most important battle-
grounds' in the struggle with the microbe [12].
Countries with low Power Distance, in contrast, show a
preference for shared decision-making in which the
patient discloses his concerns and point of view, e.g. with
regard to the pros and cons of antibiotics. It is true that
patients often put pressure on the physician to prescribe
antibiotics but doctors often overestimate patients
demand [8]. Taking the time to talk about patients' con-
cerns and to make patient expectations explicit has been
promoted as a good strategy to attain a more rational use
of antibiotics [10,37,38]. The finding that Power Distance
is relevant with regard to use of antibiotics is in line with
other studies [37] that indicate that doctor-patient rela-
tionship and dissatisfaction with the doctor is an impor-
tant determinant of antibiotic misuse. Of four types of
patients (involved, deferent, ignored and critical types),
the involved patients, i.e. those who ensure they are part
of the decision-making process and seeing themselves as
equal to the doctor, have views on and usage of antibiotics
most in line with the medical views [37]. Therefore,
changing the patient to the more involved type is sug-
gested as a strategy to limit the use of antibiotics. However
this might be more difficult in countries with high Power
Distance.
If we apply the avoidance of uncertainty to medical situa-
tions, patients and physicians are expected to have an
aversion to diagnostic uncertainty and will prefer a clear
labelling of diseases. However, many symptoms, such as
coughing, sore throat, mild fever, etc. are difficult to label
and remarkable cross-cultural variations have been found
[24,39]. Based on a clinical examination of the patient, it
is often impossible to determine whether the problem is
caused by a (self-limiting) viral infection or a bacterial
infection, in which cases antibiotics might be warranted
[40]. Although many infections are self-limiting diseases
and it is often good practice to 'wait and see', in cultures
with a high avoidance of uncertainty, physicians might
feel the inner urge 'to do something' and to fulfil the
expected role of the expert who always has a solution.
Hence they are more likely to start using antibiotics imme-
diately, probably with a preference for the newest and
strongest broad-spectrum antibiotics. When Uncertainty
Avoidance is high, rather than returning home with the
message that 'the doctor does not know' what disease they
have or how to cure it, they accept the known risks of
using antibiotics. In the latter case, patients feel confident
that they have a disease with a clear cause that is under
control. The above attitude of avoiding any risk is known
as defensive medicine and leads to unnecessary high med-
ical consumption [41].
Self-medication might be intuitively expected to be an
expression of individualism. Talking F Rahme's saying
into account "If I use an antibiotic too much, I am making
it less useful for everyone" [42] we also should expect
Individualism to be linked to higher use of antibiotics.
Contrary to these expectations, we did not find a signifi-
cant positive correlation for either self-medication or pre-
scribed use of antibiotics. However, the inversion from
negative to slightly positive correlations when controlling
for GDP per capita suggests that the wealth of a country
might have an effect on its use of antibiotics [20]. A
hypothesis needing further exploration is that Individual-
ism, in the sense that the interests of the individual prevail
over the interests of the group, leads to higher use of anti-
biotics but that the effect on country-level is completely
masked by the wealth of a country.
The results with regard to Long-term orientation are not
conclusive, probably because of the limited number of
countries for which correlation could be calculated.
We found few differences between the effects of cultural
dimensions on prescribed use of antibiotics versus self-
medication. This suggests that in countries with high inci-
dence of self-medication with antibiotics, the prescription
of antibiotics is also high [43] and that self-medication
and prescribing are practices affected by the same cultural
dimensions. This adds evidence to the hypothesis that,
although the physician is formally the only person to
decide whether or not antibiotics should be used, the final
decision is the result of a complex interaction between
patient and physician in a particular cultural context.
There is no indication in our data that with regard to the
use of antibiotics the behaviour of physicians is less
dependent on the local cultural context than that of lay
people (patients).
The finding that, after controlling for GDP/capita, the cor-
relations become insignificant for Power Distance and
Uncertainty Avoidance illustrates the complex relation-
ship between a country's wealth and cultural dimensions.
Also correlation values for Masculinity change. The origi-
nal positive insignificant correlations become stronger
(significantly for the Eurobarometer data) which is an
indication of the complex relationship between wealth
and cultural dimensions. Other studies have pointed out
a possible effect of cultural dimensions on wealth and vice
versa: Power Distances covaries negatively with a coun-
try's wealth. Uncertainty Avoidance influences consumer
behaviour. Masculinity affects the way countries spent
their money (e.g. masculine countries are inclined to pri-
oritise economic growth over care for the environmentPage 6 of 9
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with economic growth. [20,33]
Our study has some limitations. First, due to the selection
of regions in the SAR study, it is not certain that the cho-
sen regions really reflect the national culture of these
countries. Also the response rate for the SAR data was low
in some countries. We therefore repeated the analysis,
limited to countries with response rates of >40%. We also
plotted the results and checked for the effect of possible
outliers. These verifications corroborated our results. We
also used data from others studies, based on other data
sources and sampling methods to minimise the biases
and restrictions of each particular study. Secondly, since
we tested correlations for 5 cultural dimensions the
chance of finding statistically significant correlations by
chance increases in one dataset. We used different data
sets to test hypotheses that were formulated before the
data were available. Nevertheless extra care is warranted in
interpreting the results. Thirdly, culture is certainly a
much richer phenomenon than the reduction into 5
dimensions presented and Hofstede has been criticized
for trying 'to measure the immeasurable'. [44,45] How-
ever, equivalents of Hofstede's cultural dimensions have
been found by several other authors and his cultural
dimensions have been validated in multiple other studies
[20,32]. Finally, as in most cross country comparisons the
N is rather low, and the study may be underpowered to
detect smaller differences between countries.
The VSM questionnaire has been developed to compare
countries. It is not meant to compare individuals but to
describe relative differences between social systems only.
A common pitfall is to look at culture as a kind of collec-
tive personality. Such an interpretation neglects the fact
that cultures are the result of interaction between different
– at the same time conflicting and complementary – per-
sonalities [20]. Therefore, this study is done at the aggre-
gated level of the country. The use of data aggregated at
the country level requires extra caution to avoid the well-
known ecological fallacy. Therefore, significant associa-
tions do not necessarily imply a causal relation.
We are also aware of the fact that cultural dimensions
might be the resultant of important factors (as we showed
for the impact of GDP). However, the strength of cultural
dimensions is that they are the resultant of many interact-
ing factors and that they can put phenomena together that
initially seem unconnected. An advantage is also that they
enable quantitative analysis of cultural aspects in relation
to other relevant issues such as the use of antibiotics. This
is not possible using thicker descriptions of cultures, i.e.
anthropological descriptions based on qualitative data.
Therefore, we believe cultural dimensions are a simple but
useful tool to measure the extremely complex concept of
culture. Up till now, this approach has seldom been used
to improve our understanding of the remarkable and par-
tially unexplained national differences in antibiotic us,
but has been successfully employed in dozens of studies,
e.g. on management and communication [46-48]. It pro-
vides a novel approach that may also be inspiring to
explain other differences in the use of medical care.
Conclusion
In summary, our study indicates that Power Distance is a
cultural aspect associated with antibiotics use, suggesting
that the culture-specific way people deal with authority is
an important factor in explaining cross-national differ-
ences in antibiotic use. Uncertainty Avoidance can lead to
high consumer demand and defensive medicine, which
may result in unnecessary use of antibiotics. The effect of
cultural dimensions is complex because they influence a
multitude of social phenomena on the macro and micro
level, such as the wealth of a country. Further cross-
national comparative research, e.g. based on larger sam-
ples and including also non-Western countries, is needed
to better understand the correlations between cultural
dimensions and the use of antibiotics and the reasons for
this, so that our hypothetical explanations can be corrob-
orated or falsified.
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